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Microglia are the resident brain macrophages and they have been traditionally
studied as orchestrators of the brain inflammatory response during infections and
disease. In addition, microglia has a more benign, less explored role as the brain
professional phagocytes. Phagocytosis is a term coined from the Greek to describe
the receptor-mediated engulfment and degradation of dead cells and microbes. In
addition, microglia phagocytoses brain-specific cargo, such as axonal and myelin debris
in spinal cord injury or multiple sclerosis, amyloid-β deposits in Alzheimer’s disease, and
supernumerary synapses in postnatal development. Common mechanisms of recognition,
engulfment, and degradation of the different types of cargo are assumed, but very
little is known about the shared and specific molecules involved in the phagocytosis of
each target by microglia. More importantly, the functional consequences of microglial
phagocytosis remain largely unexplored. Overall, phagocytosis is considered a beneficial
phenomenon, since it eliminates dead cells and induces an anti-inflammatory response.
However, phagocytosis can also activate the respiratory burst, which produces toxic
reactive oxygen species (ROS). Phagocytosis has been traditionally studied in pathological
conditions, leading to the assumption that microglia have to be activated in order
to become efficient phagocytes. Recent data, however, has shown that unchallenged
microglia phagocytose apoptotic cells during development and in adult neurogenic niches,
suggesting an overlooked role in brain remodeling throughout the normal lifespan. The
present review will summarize the current state of the literature regarding the role of
microglial phagocytosis in maintaining tissue homeostasis in health as in disease.
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Abbreviations: ACAMPs, apoptotic cells-associated cellular patterns; AD,
Alzheimer’s disease; AIF, apoptosis-inducing factor; APCs, antigen presenting
cells; APP, amyloid precursor protein; ASD, autism spectrum disorders; ATP,
adenosine trinucleotide phosphate; Aβ, amyloid beta; BAI-1, brain-specific
angiogenesis inhibitor 1; CAD, caspase-activated DNAse; CNS, central nervous
system; CR1, complement receptor 1; DAP12, DNAX-activation protein X; DCs,
dendritic cells; DOCK-180, dedicator of cytokinesis 180; EAE, experimental acute
encephalomyelitis; ELMO, engulfing and cell motility protein; HMGB1, high
mobility group 1 protein; Hsp60, heat shock protein 60; IFNγ, interferon gamma;
IGF-1, insulin-like growth factor 1; IL-10, interleukin 10; IL-1β, interleukin 1beta;
IL-4, interleukin 4; LPS, bacterial lipopolysaccharides; MBP, myelin basic protein;
MCAO, medial cerebral artery occlusion; MFG-E8, milk fat globule-epidermal
growth factor; MHC-II, major histocompatibility complex class II; MS, multiple
sclerosis; NADPH, nicotinamide adenine dinucleotide phosphate; NGF, neural
growth factor; PAMPS, pathogen-associated molecular patterns; PCD, pro-
grammed cell death; PD, Parkinson’s disease; PLOSL, polycystic lipomembranous
osteodysplasia with sclerosing leukoencephalopathy; PNS, peripheral nervous
system; PS, phosphatidylserine; RAGE, receptor for advanced glycation end
products; ROS, reactive oxygen species; RPE, retinal pigment epithelium; SIRPα,
signal regulatory protein alpha; SVZ, subventricular zone; TAMs, tumor-associated
macrophages; TGFβ, transforming growth factor beta; TLRs, Toll-like receptors;
TNFα, tumor necrosis factor alpha; TREM2, triggering receptor expressed on
myeloid cells-2; TRIF, TIR domain-containing adapter inducing interferon beta;
UDP, urydil dinucleotide phosphate; UTP, urydil trinucleotide phosphate; WD,
Wallerian degeneration.
DEFINITION OF PHAGOCYTOSIS
Phagocytosis is a Greek-derived term which literally means the
cellular process of eating. It describes the recognition, engulf-
ment, and degradation of large (>0.5μm), particulated organ-
isms or structures (Mukherjee et al., 1997). Phagocytosis of
invading microorganisms by immune cells was first discovered by
the father of cellular immunology Ilya Metchnikoff in 1882, for
which he was awarded the Nobel Prize. Most cell types, including
unicellular organisms, have the capacity to phagocytose. Inmulti-
cellular organisms, and more particularly in animals with a well-
developed immune system, phagocytosis is mostly performed
by specialized, professional phagocytes: macrophages, dendritic
cells (DCs), and neutrophils. Together with inflammation, phago-
cytosis composes the first line of defense against multicellular
organisms by the innate immune system. In jawed vertebrates,
including mammals, phagocytosis also helps to initiate the more
specific adaptive immune response through antigen-presentation
to T lymphocytes (Litman et al., 2005). In the mammalian
central nervous system (CNS), the innate immune response is
orchestrated by microglia.
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Microglia are the brain resident macrophages. They are of
myeloid origin and share many properties with other well-studied
tissue macrophages. However, they have a different origin and are
a unique macrophage cell type in the adult organism. Microglia
are yolk sac-derived, invade the brain during early embryonic
development and then locally proliferate in the brain (Ginhoux
et al., 2010; Schulz et al., 2012). In contrast to other yolk sac-
derived macrophages, they are not replaced during the post-
natal period and later life by liver- or bone marrow-derived
macrophages (Hoeffel et al., 2012). Cell biology of phagocyto-
sis has been mainly established on bone marrow-derived tissue
macrophages. In this review we directly extrapolate basic phago-
cytic mechanisms from bonemarrow-derived tissuemacrophages
to the less-known processes of microglia, but would like to point
out that these assumed similarities might not fully hold true
to the yolk sac-derived microglia. Particularly, yolk sac-derived
macrophages including microglia may possibly have different
tasks since they are confronted with different target structures,
mainly apoptotic cells during developmental tissue remodeling,
while bone marrow-derived macrophages have a higher chance
to be confronted with pathogens, mainly during defense against
invading microbes. Overall, microglial phagocytosis is a relatively
unknown process in terms of the receptors involved, the mecha-
nisms of its execution, its beneficial or detrimental consequences,
and its ultimate impact inmaintaining tissue homeostasis. To fur-
ther complicate the issue, macrophage phagocytosis has two main
targets: dead resident cells (apoptotic or necrotic) and live invad-
ing microorganisms; whereas microglial phagocytosis appears to
be adapted to the brain environment for remodeling tasks such
as engulfment of synapses, axonal and myelin debris, or clearance
of proteins with very high turnover such as amyloid beta (Aβ)
protein.
One major limitation is that inmost studies, microglial phago-
cytosis is assessed exclusively in vitro, utilizing a model of phago-
cytosis in which primary or transformed microglial cells are “fed”
with a variety of targets, ranging from latex beads to primary or
transformed apoptotic cells, cell debris, or Aβ. These models have
proved to be extremely valuable to study the molecular pathways
involved in the recognition, engulfment, and degradation of the
targets. However, the lack of molecular tools to specifically block
these three steps has precluded our understanding of the global
impact of microglial phagocytosis in vivo. In fact, many in vivo
experiments rely on the use of phagocytosis “markers” such as
CD68 (ED1 ormacrosialin) as a proxy. One major problem is that
the function of CD68 is unknown. While located in the lysosomal
compartment, anti-CD68 antibodies do not block macrophage
phagocytosis in vitro (Damoiseaux et al., 1994), and macrophages
from mice deficient in CD68 have no defects in phagocytosis of
bacteria (Song et al., 2011). In the adult hippocampus, the expres-
sion of ED1 in microglia phagocytosing apoptotic cells is similar
to non-phagocytic microglia and much lower than the expression
induced by inflammatory challenge (Sierra et al., 2010). However,
a higher expression of ED1 seems to correlate with the capacity
of postnatal microglia to engulf synapses (Schafer et al., 2012).
Furthermore, few studies have attempted to quantify the extent
of microglial phagocytosis in vivo (Ashwell, 1990; Dalmau et al.,
2003; Parnaik et al., 2000; Sierra et al., 2010) and many rely on
a qualitative observation of microglial engulfment to determine
whether microglia is phagocytosing or not.
The rapid clearance time of dead cells is likely behind this qual-
itative rather than quantitative assessment. In vitro, live imaging
has determined that the clearance time to completely eliminate
an apoptotic cell by microglia is 25–95min in a co-culture sys-
tem (Parnaik et al., 2000); in vivo, the microglial clearance time
of apoptotic cells in physiological conditions has been estimated
to be 70–90min (Sierra et al., 2010). These numbers are in
agreement with a general 1–2 h clearance time for macrophages
(Henson and Hume, 2006). Thus, the number of apoptotic cells
observed in particular time point represents only a small fraction
of the actual number of apoptotic cells generated (or total num-
ber of cells which disappear). For example, if 400 cells die in a
24 h period, a clearance time of 1.5 h would mean that only 25
dead cells can be observed at any time point [for more details on
estimation of the clearance time, see Barres et al. (1992); Sierra
et al. (2010)]. The phagocytosis of smaller particles (synapses,
axons, protein aggregates) is likely to be even faster. The prompt-
ness of microglia to eliminate cell debris is therefore an important
parameter to take into account when analyzing the dynamics of
cell death and phagocytosis.
In addition to the clearance time, two main parameters to
quantify microglial phagocytosis of apoptotic cells in vivo using
immunofluorescence and confocal microscopy have been estab-
lished: the phagocytic index, or proportion of apoptotic cells
which are three-dimensionally engulfed by microglia over the
total number of apoptotic cells; and the phagocytic capacity,
or proportion of phagocytosing microglia multiplied by the
number of phagocytic pouches (i.e., number of apoptotic cells
engulfed) over the total number of microglia (Sierra et al., 2010).
More recently, a similar parameter was described to quantify
microglial phagocytosis of synaptic inputs (allegedly, presynap-
tic terminals) using high resolution confocal microscopy and
three-dimensional rendering to estimate the volume of internal-
ized inputs over the total volume of microglia (Schafer et al.,
2012). Similarly, microglial phagocytosis of axonal or myelin
debris can be quantified using confocal microscopy to determine
the percentage of microglia containing neurofilament-positive
axonal material (Hosmane et al., 2012) or myelin basic protein
(MBP) (Nielsen et al., 2009). The utilization of these or similar
parameters is a necessary starting point to obtain a quantitative
picture of microglial phagocytosis across a range of physiolog-
ical and pathological conditions, which will help us to address
many of the open questions. Over the next sections, we will
provide an overall description of the mechanical process of
phagocytosis; its beneficial and detrimental consequences; and
the particular details of phagocytosis of different targets: cells
and cell debris, microorganisms, tumor cells, spines, and Aβ
deposits.
THE MECHANICS OF PHAGOCYTOSIS
Our current understanding of the mechanical process of phago-
cytosis is summarized in the three-step model: find-me, eat-me,
and digest-me (Savill et al., 2002), which addresses the engulf-
ment and degradation of apoptotic cells and microorganisms by
macrophages and DCs. While it is likely that microglia utilizes
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similar mechanisms, direct evidence of the molecular details of
these events in microglia, beyond the receptors involved in the
recognition of the targets, is largely missing. In this section, we
will address the featured molecular mechanisms in the process of
phagocytosis by microglia (Figure 1).
FIND-ME
The process is initiated when the phagocyte encounters a tar-
get, either randomly or triggered by signals from the target.
Microglial processes are highly motile (Davalos et al., 2005;
Nimmerjahn et al., 2005) and their constant surveillance of
the brain parenchyma supports their capacity to fortuitously
encounter targets to engulf. In addition, apoptotic cells can release
signals to attract macrophages and DCs, such as the extracellular
nucleotides ATP and UTP (Elliott et al., 2009). Inmicroglia, UDP,
the product of degradation of UTP by extracellular ectonucleoti-
dases, acts on P2Y6 receptors to facilitate phagocytosis (Koizumi
et al., 2007). Another important chemotactic signal released by
apoptotic cells is fractalkine/CX3CL1 (Truman et al., 2008; Noda
et al., 2011).Microglia express the fractalkine receptor (CX3CR1),
which promotes phagocytosis of apoptotic cells (Noda et al.,
2011) but shifts microglia toward a phenotype with less capac-
ity to phagocytose Aβ (Lee et al., 2010; Liu et al., 2010). Once the
phagocyte has reached the target a direct cell membrane contact
is established via a receptor-ligand interaction and phagocytosis
takes place.
EAT-ME
The process of recognition and engulfment of the targets is,
arguably, the most important step in phagocytosis and where
most research is concentrated. Phagocytes are equipped with a
likely complementary array of receptors which enable them to
recognize their targets (the so-called “eat-me” signals) and dis-
criminate them from the remaining parenchyma, particularly
from living cells (which express “don’t-eat-me” signals) (Savill
et al., 2002; Ravichandran, 2010). Some of these receptors serve
to tether the phagocyte and the target together; others actually
trigger internalization (Underhill and Goodridge, 2012). These
receptors can be classified into two main types depending on
their targets. Detection of pathogen-associated molecular pat-
terns (PAMPS) is mediated through scavenger receptors in con-
junction with Toll-like receptors (TLRs) such as the CD14/TLR4
complex, or receptors of the immunoglobulin superfamily (e.g.,
c-type lectins). Detection of apoptotic cells-associated cellular
patterns (ACAMPs), of which exposure of phosphatidylserine
(PS) in the outer leaflet of the cell membrane is the main
exponent, is mediated directly by several receptors, includ-
ing brain-specific angiogenesis inhibitor 1 [BAI-1; reviewed in
Armstrong and Ravichandran (2011)], and by bridgingmolecules
such as milk fat globule-epidermal growth factor (MFG-E8).
Another important receptor that signals internalization is trigger-
ing receptor expressed on myeloid cells-2 (TREM2), whose loss
of function prevents microglial phagocytosis (Takahashi et al.,
2005; Hsieh et al., 2009). TREM2 is known to interact with
the signaling adapter protein named DNAX-activation protein
of 12 kD (DAP12) (Paloneva et al., 2002), however its ligand
in apoptotic cells remains elusive. Several candidates have been
proposed, namely, anionic oligosaccharides such as bacterial
lipopolysaccharides (Daws et al., 2003; Quan et al., 2008) and heat
shock protein 60 (Hsp60) (Stefano et al., 2009). Hsp60 is exposed
in the surface of apoptotic cells (Goh et al., 2011) and increases
the phagocytic activity of microglia (Stefano et al., 2009). In
addition to the direct recognition of the targets by microglial
cell membrane receptors, engulfment can also triggered by sol-
uble opsonins that bind to receptors signaling internalization
in the microglia. Antibodies such as IgG and proteins of the
complement system such as C3b, bind to phagocyte Fc recep-
tors and complement receptor 3 (CR3), respectively, and mediate
phagocytosis (Underhill and Goodridge, 2012). Further exam-
ples of receptors and their targets are summarized in Table 1
and Figure 2 and will be provided in the following sections. The
level of expression of the receptors involved in phagocytosis may
FIGURE 1 | Three-step model of microglial phagocytosis. In physiological
conditions, microglial processes are highly motile and respond to
chemoattractant molecules released by damaged or apoptotic cells
(“find-me” signals) such as fractalkine and extracellular nucleotides (ATP,
UDP). Next, an engulfment synapse is formed between a series of microglial
receptors and their ligands in the membrane of the apoptotic cell (“eat-me”
signals), leading to the tethering and engulfing of the apoptotic cell in a
phagosome. The phagosome becomes mature by fusing with lysosomes
and other organelles, and the apoptotic cell is fully degraded in the
phagolysosome in less than 2h (see text for details).
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Table 1 | Summary of receptors involved in macrophage and microglial phagocytosis.
Receptors Ligands Macrophages function References Microglia function References
PS RECEPTORS
BAI-1 PS Phagocytosis of apoptotic
cells
Flannagan et al., 2012;
Kim et al., 2012
Phagocytosis of apoptotic
cells
Park et al., 2008
MER PS [Gas 6, protein S] Phagocytosis of apoptotic
cells
Ravichandran, 2010 Phagocytosis of apoptotic
cells
Grommes et al., 2008
PSR PS Phagocytosis of apoptotic
cells
Taylor et al., 2005 Phagocytosis of apoptotic
cells
De Simone et al., 2003
Stabilin-2 PS Phagocytosis of apoptotic
cells
Ravichandran, 2010;
Flannagan et al., 2012
Function in phagocytosis
unreported
N/R
TIM-1 PS Phagocytosis of apoptotic
cells
Flannagan et al., 2012 Phagocytosis of apoptotic
cells
Noda and Suzumura,
2012
TIM-4 PS Phagocytosis of apoptotic
cells
Freeman et al., 2010;
Flannagan et al., 2012
Phagocytosis of apoptotic
cells
Mizuno, 2012; Noda
and Suzumura, 2012
INTEGRIN RECEPTORS
avβ5 PS, vitronectin
[MFG-E8,
thrombospondin]
Phagocytosis of apoptotic
cells
Dupuy and Caron, 2008 Expressed. Function in
phagocytosis unreported
Welser-Alves et al.,
2011
CR1 MBL, C1q, C4b, C3b,
C3bi
Adhesion to
bacteria/pathogens
Fallman et al., 1993;
Flannagan et al., 2012
Adhesion to opsonized
erythrocytes
Ulvestad et al., 1994;
Linnartz and Neumann,
2012
CR3 C3 and C1q [DAP12] Adhesion to opsonized
yeast particles;
phagocytosis of bacteria;
opsonized apoptotic cells;
degenerated myelin and
neurites
Fallman et al., 1993;
Rotshenker, 2009;
Linnartz and Neumann,
2012
Adhesion to opsonized
yeast particles;
phagocytosis of bacteria;
opsonized apoptotic cells;
degenerated myelin and
neurites
Rotshenker, 2009;
Linnartz and Neumann,
2012; Schafer et al.,
2012
CR4 iC3b Phagocytosis of
opsonized apoptotic cells
Flannagan et al., 2012 Phagocytosis of
opsonized apoptotic cells
Crehan et al., 2012
VnR PS, vitronectin
[MFG-E8,
thrombospondin]
Adhesion to apoptotic
cells; phagocytosis of
apoptotic cells
Dupuy and Caron, 2008 Phagoptosis (killing of
viable neurons)
Neher et al., 2011;
Welser-Alves et al.,
2011
IG SUPERFAMILY RECEPTORS
FcγRI IgG1 = IgG3 > IgG4 Phagocytosis of
degenerated myelin
Rotshenker, 2009 Phagocytosis of
degenerated myelin
Noda and Suzumura,
2012
FcγRIIa IgG3 ≥ IgG1 = IgG2 Phagocytosis of
pathogens and apoptotic
cells
Hart et al., 2004 Phagocytosis of
pathogens and apoptotic
cells
Linnartz and Neumann,
2012
RAGE Aβ, AGEs, PS, and
HMGB1, C1q
Phagocytosis of apoptotic
cells
He et al., 2011 Mediates
pro-inflammatory effect
of Aβ
Block et al., 2007; Noda
and Suzumura, 2012
Siglec11 α2,8-linked polysialic
acids
Reduced phagocytosis of
apoptotic cells
Linnartz and Neumann,
2012
Reduced phagocytosis of
apoptotic cells
Wang and Neumann,
2010; Linnartz and
Neumann, 2012
SIRPα Myelin [SP-A, D;
CD47]
Recognition and
downregulation of
phagocytosis of myelin
Linnartz and Neumann,
2012
Recognition and
downregulation of
phagocytosis of myelin
Ransohoff and Perry,
2009; Noda and
Suzumura, 2012
SIRPβ1 Unknown ligand
[DAP12]
Increase of phagocytosis
of opsonized red blood
cells
Hayashi et al., 2004;
Gaikwad et al., 2009
Phagocytosis of neuronal
debris, fibrillary Aβ, latex
beads
Gaikwad et al., 2009;
Linnartz and Neumann,
2012
TREM2 Hsp60,
oligosaccharides
[DAP12]
Phagocytosis of apoptotic
cells
Klesney-Tait et al., 2006 Phagocytosis of apoptotic
cells
Klesney-Tait et al.,
2006; Ransohoff and
Perry, 2009
(Continued)
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Table 1 | Continued
Receptors Ligands Macrophages function References Microglia function References
SCAVENGER AND RELATED RECEPTORS
CD36 Ox-LDL, Ox-PS
[thrombospondin]
Adhesion to apoptotic
cells; phagocytosis of
apoptotic cells
Greenberg et al., 2006;
Flannagan et al., 2012
Phagocytosis of apoptotic
cells
Noda and Suzumura,
2012
CD68 Ox-LDL Adhesion to erythrocytes Hoffmann et al., 2001 Phagocytic marker.
Function in phagocytosis
unreported
Fulci et al., 2007
LOX-1 LDL, Ox-LDL, Hsp70 Phagocytosis of
aged/apoptotic cells
Taylor et al., 2005 Expressed.
Pro-inflammatory
response. Function in
phagocytosis unreported
Zhang et al., 2012
MARCO Ac-LDL, bacteria Adhesion to unopsonized
particles and bacteria;
phagocytosis of bacteria,
apoptotic cells, and
unopsonized latex beads
van der Laan et al.,
1999; Rogers et al.,
2009
Decrease of antigen
internalization capacity;
adhesion to Aβ, bacteria;
decreased bead
phagocytosis
Granucci et al., 2003;
Block et al., 2007
SR-A LPS, lipotheicoic acid,
Ac-LDL
Adhesion to apoptotic
thymocytes;
phagocytosis of bacteria,
apoptotic cells, and
degenerated myelin
Savill et al., 2002; Taylor
et al., 2005; Flannagan
et al., 2012
Phagocytosis of bacteria,
apoptotic cells,
degenerated myelin and
Aβ
Block et al., 2007;
Wilkinson and El
Khoury, 2012
SR-B1 HDL, LDL, Ox-HDL,
Ox-LDL, advanced
glycosylation end
products
Phagocytosis of bacteria
and apoptotic cells
Boullier et al., 2001 Adhesion to Aβ,
phagocytosis of apoptotic
cells, and endocytosis of
fibrillar Aβ
Block et al., 2007
TLR2 Pam3Cys/Glycolipids,
Hsp70, HMGB1
Function in phagocytosis
unreported
N/R Phagocytosis of Aβ Landreth and
Reed-Geaghan, 2009;
Noda and Suzumura,
2012
TLR4 LPS, lipotheicoic acid,
Hsp60,70;
co-receptor CD14
Phagocytosis of bacteria Anand et al., 2007;
McCoy and O’Neill,
2008
Bacterial recognition;
phagocytosis of Aβ
Block et al., 2007; Noda
and Suzumura, 2012
C-TYPE LECTIN RECEPTORS
Dectin-1 β glucans Phagocytosis of yeast,
fungus
Lowell, 2011; Flannagan
et al., 2012
Phagocytosis of yeast,
fungus
Shah et al., 2008
MR Mannose, fucose Phagocytosis of
pathogens
Flannagan et al., 2012 Phagocytosis of yeast Marzolo et al., 1999;
Zimmer et al., 2003
OTHER RECEPTORS
β2-GPI
receptor
(unidentified)
PS [β2-GPI] Phagocytosis of apoptotic
cells
Lauber et al., 2004;
Taylor et al., 2005
Function in phagocytosis
unreported
N/R
CD91 Multiprotein complex
(calreticulin, MBL,
C1q), HSPs
Initiate engulfment of
apoptotic cells
Ogden et al., 2001 Function in phagocytosis
unreported
Pais et al., 2008
Receptors have been classified into major functional/structural groups: PS receptors, integrin receptors, Ig superfamily receptors, scavenger and related receptors,
C-type lectin receptors, and others. Bridging molecules are indicated in brackets.
Abbreviations: Aβ, amyloid beta protein; Ac-LDL, acetylated low density lipoprotein; AGEs, advanced glycation end products; BAI-1, brain angiogenesis inhibitor 1;
CR, complement receptor; DAP12, DNAX-activation protein of 12 KDa; HDL, high density lipoprotein; HMGB1, high-mobility group box 1 protein; Hsp, heat-shock
protein; LDL, low density lipoprotein; LOX-1, lectin-like oxidized LDL receptor-1; LPS, bacterial lipopolysaccharides; MAC-1, macrophage antigen complex 1; MARCO,
macrophage receptor with collagenous structure; MBL, mannan-binding lectin; Mer-TK, Mer tyrosine kinase; MFG-E8, milk fat globule-epidermal growth factor;
MR, mannose receptor; N/R, non-reported; Ox-HDL, high density lipoprotein; Ox-LDL, oxidized low density lipoprotein; Ox-PS, oxidized phosphatydilserine; PS,
phosphatydilserine; PSR, phosphatydilserine receptor; RAGE, receptor for advanced glycation endproducts; Siglec11, sialic acid binding immunoglobulin-like lectin 11;
SIRPα, signal regulatory protein alpha; SIRPβ1, signal regulatory protein beta 1; SP, surfactant protein; SR, scavenger receptor; TIM, T-cell-immunoglobulin-mucin;
TLR, toll-like receptor; TREM2, triggering receptor expressed on myeloid cells 2; VnR, vitronectin receptor.
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FIGURE 2 | Receptors involved in microglial phagocytosis of endogenous
structures. (A), Apoptotic cells; (B), Neurites; (C), Aβ aggregates/fibrils;
(D), Myelin debris. Receptors have been classified into major
functional/structural groups: phosphatidylserine (PS) receptors, integrin
receptors, Ig superfamily-receptors, and scavenger and related receptors. For
more details on the receptors, refer to Table 1. For receptors involved in the
recognition of necrotic cells andmicrobes, refer to themain text. Abbreviations:
Aβ, β-amyloid protein; BAI-1, brain angiogenesis inhibitor 1; CR, complement
receptor; DAP12, DNAX-activation protein of 12 KDa; Hsp60, heat-shock
protein of 60KDa; MARCO, macrophage receptor with collagenous structure;
Mer-TK, Mer tyrosine kinase; MFG-E8, milk fat globule-epidermal growth
factor; Ox-LDL, oxidized low density lipoprotein; PS, phosphatidylserine; PSR,
phosphatidylserine receptor; SIRPβ1, signal regulatory protein β1; SR-A,
scavenger receptor class A; SR-B1, scavenger receptor class B1; TIM,
T-cell-immunoglobulin-mucin; TLR, toll-like receptor; TREM2, triggering
receptor expressed on myeloid cells 2; VnR, vitronectin receptor.
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change under different stimuli such as inflammation (Falsig et al.,
2008), but it is not known whether they ultimately impact the
efficiency of microglial phagocytosis.
These receptors and their targets closely interact in what
has been termed “engulfment synapse” or “phagocytic synapse”
(Ravichandran, 2010; Dustin, 2012; Underhill and Goodridge,
2012). Similar in size (0.5μm in diameter) and purpose (close
cell–cell contact) to its immunological and neural counterparts,
phagocytic synapses are specialized regions of the membrane
where the apoptotic cell and the phagocyte interact through
microclusters of receptors. Like the immunological synapse
formed between antigen presenting cells (APCs) and T lympho-
cytes, and in contrast to the synapses formed between neurons,
phagocytic synapses are short-lived and last only a few min-
utes (Dustin, 2012). Phagocytic synapses are also characterized
by exclusion of phosphatases (Dustin, 2012), so that once the
contact is established the signal is transduced by a variety of intra-
cellular kinases (Syk kinase, phosphatidylinositol 3-kinase) and
small GTPases (Rac, Rho) and adapter molecules such as engulf-
ing and cell motility (ELMO) family (Gumienny et al., 2001; Lee
et al., 2007). An emerging pivotal complex is that formed by
ELMO-1 and dedicator of cytokinesis 180 (DOCK-180), which
is activated among other receptors by BAI-1 and act as a gua-
nine nucleotide exchange factor for Rac (Park et al., 2008; Patel
et al., 2011). ELMO-1 function is regulated by phosphorylation
by the hematopoietic cell kinase (HCK) (Yokoyama et al., 2005),
a member of the Src family whose deficiency impairs macrophage
phagocytosis (Lowell et al., 1994). These pathways lead to the
remodeling of the phagocyte cytoskeleton through actin poly-
merization andmembrane composition, triggering the formation
of pseudopodia that form a phagocytic cup engulfing the target
(Lee et al., 2007). Of the complex process of signal transduc-
tion and formation of the phagocytic cup, very little is known in
microglia.
DIGEST-ME
The phagocytic cup closes and thus forms the phagosome around
the target. To execute the degradation of the target, phagosomes
go through a process of maturation in which they fuse sequen-
tially with early and late endosomes, and lysosomes, to form
phagolysosomes (Desjardins et al., 1994). These phagolysosomes
contain hundreds of proteins, including hydrolases such as
cathepsins to digest the target; and proton pumps such as vac-
uolar ATPases to acidify the medium (Garin et al., 2001). The
acidic pH found in phagolysosomes (pH ≤ 5) is essential for
the lysosomal degradation capabilities, as it is optimal for most
hydrolases. Interestingly, the signaling associated with the acidic
pH of lysosomes deactivates the generation of radicals from the
oxidative burst (Li et al., 2010). Again, the process of phago-
some formation and cargo degradation has been barely addressed
in microglia. A recent study in C. elegans using live imaging
showed that in this nematode microglial vATPases are required
for phagosome–lysosome fusions and consequently to degrade
cargo (Peri and Nusslein-Volhard, 2008). Further research is nec-
essary to delineate the mechanisms of degradation of structurally
different cargo, ranging from Aβ deposits to whole apoptotic
cells, in microglia. Moreover, because phagocytosis is not only
performed by ameboid, activated cells but also by terminal or
en passant branches of ramified, resting microglia (Peri and
Nusslein-Volhard, 2008; Sierra et al., 2010), the location where
the actual degradation occur remains unexplored. Live imag-
ing experiments show that resembling phagosomal cups are
retrogradely transported to the cell soma in the mouse neocor-
tex (Nimmerjahn et al., 2005); small puncta of apoptotic cell
material are observed within branches of ramified microglia in
fixed adult hippocampus, indirectly suggesting their transport
(Sierra et al., 2010). Direct evidence of retrograde transport
of cargo-containing phagosomes was recently found in C. ele-
gans (Peri and Nusslein-Volhard, 2008). Collectively, these data
indirectly suggest a yet unexplored role of the cytoskeleton in
transporting the phagosome for the degradation of the engulfed
material.
Overall, phagocytosis is considered to be essential for main-
taining brain tissue homeostasis. The rapid clearance of apoptotic
cells prevents their transformation into secondary necrotic cells
(as it readily occurs in vitro), with the subsequent loss of per-
meability of the cell membranes and spillover of intracellular
contents. For instance, the phagocytosis of apoptotic neutrophils
and T cells during the resolution of the inflammatory response
prevents the release of intracellular granules containing lysoso-
mal enzymes and possibly acidification of the extracellular space
(Magnus et al., 2001). Further, blockade of microglial phagocyto-
sis of polymorphonuclear neutrophils, which infiltrate the brain
parenchyma after focal ischemia, decreases neuronal viability in
organotypic slices (Neumann et al., 2008). Phagocytosis of apop-
totic neurons is also beneficial for neuronal survival. For instance,
neurons can be rescued from excitotoxic death when phagocyto-
sis is promoted by the chemokine fractalkine in neuron-microglia
co-cultures, but not in neuronal cultures alone (Noda et al., 2011).
In addition, myelin debris contains inhibitory molecules which
inhibit axonal regeneration (Gitik et al., 2011); Aβ plaques cause
physical damage of the neural tissue and lead to functional deficits
if they are not removed (Wang et al., 2011); and removal of axonal
debris by microglia increases axonal regeneration in vitro (Tanaka
et al., 2009; Hosmane et al., 2012).
In the living brain, however, the beneficial effects of microglial
phagocytosis have been harder to prove, possibly due to the lack
of molecular tools to specifically interfere with microglial phago-
cytosis. Enhancing brain phagocytosis via intravenous deliv-
ery of TREM2-transduced bone marrow-derived precursor cells
potentiates the clearance of degenerated myelin, decreases the
inflammatory response and ameliorates the course of the dis-
ease in the mouse model of multiple sclerosis (MS), experi-
mental acute encephalomyelitis (EAE) (Takahashi et al., 2007).
A method recently proposed is the use of annexin V, a PS
binding protein, to block phagocytosis. When administered sys-
temically, annexin V reaches the brain and, as expected, leads
to accumulation of apoptotic debris, although it has not been
quantified whether it actually prevents phagocytosis (Lu et al.,
2011). Treatment with annexin V impaires the generation of
newborn neurons in adult neurogenic niches without affect-
ing the proliferation of neuronal precursors, suggesting that
phagocytosis is important for the differentiation and/or sur-
vival of the newborn cells (Lu et al., 2011). Direct evidence
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of the beneficial effects of microglial phagocytosis was shown
recently in a mouse model of Rett syndrome by knocking out the
methyl-CpG-binding protein Mecp2 (Derecki et al., 2012). While
Rett syndrome is mostly considered a primary neuronal disease,
defects in phagocytosis and inflammatory response are found in
Mecp2-deficient microglia (Derecki et al., 2012). Further, bone
marrow cells transplanted into irradiated Rett mice differentiate
into microglia and partially arrest the pathology of the dis-
ease (Derecki et al., 2012). Interestingly, the disease is mimicked
by microglial-specific depletion of Mecp2 and phagocytosis is
blocked by intravenous injection of annexin V, but not by either
manipulation independently. These data suggest that a failure in
microglial phagocytosis does not underlie the pathology of the
Rett syndrome but, nonetheless, increasing phagocytosis may be
beneficial (Derecki et al., 2012).
FUNCTIONAL CONSEQUENCES OF PHAGOCYTOSIS
Clearance of microbes or debris is a direct intervention of
microglia to remove invading pathogens or to clean up the tis-
sue from unwanted material. The direct consequences of this
clearance function were already described in the chapter above.
Furthermore, ingestion and degradation of targets has several
indirect consequences for the phagocyte as well as the sur-
rounding tissue. Phagocytosis triggers activation of several intra-
cellular signaling pathways and remodels the cytoskeleton and
cell membrane (Lee et al., 2007). In addition, microglia receive
a tremendous metabolic load from the lipids, carbohydrates,
proteins, and other components from the digested target (par-
ticularly in the case of apoptotic cells and microorganisms),
leading to direct changes in the phagocyte’s lipid and choles-
terol, and possibly glucose metabolism (Han and Ravichandran,
2011). In addition, whether phagocytosis impacts proliferation,
survival, or differentiation of the phagocyte remains unexplored.
In contrast, three major functional consequences of microglial
phagocytosis have been well-described: antigen presentation,
activation of the respiratory burst, and modulation of inflamma-
tory responses.
ANTIGEN PRESENTATION
Professional APCs (macrophages, DCs, and B lymphocytes)
engulf their targets locally; next, they travel to lymph nodes,
where the digested exogenous proteins (antigens) are expressed
in their membrane attached to specific receptors (major his-
tocompatibility complex class II, or MHC-II), which enable
their recognition by naïve T lymphocytes, initiating the cel-
lular arm of the adaptive immune response. Antigen presen-
tation is a complex process beyond the scope of this review.
Nonetheless, it is important to note that antigen presentation
in the CNS has been a matter of hot debate in the last few
years [reviewed by Ransohoff and Engelhardt (2012)]. In nor-
mal conditions, microglia do not express MHC-II and only a
subpopulation expresses co-stimulatory molecules such as CD11c
(Bulloch et al., 2008), and in agreement they have poor anti-
gen presenting activity in vivo (Ford et al., 1995). Upon local
inflammatory challenge, microglia show increased expression of
MHC-II and CD11c in vivo and increased antigen presentation
in vitro, albeit with much lower efficiency than professional APCs
(Gottfried-Blackmore et al., 2009). While it is clear that they
have the capacity of presenting antigens under some particular
conditions, the microglial contribution to antigen presentation
in vivo is thought to be mostly irrelevant (Galea et al., 2007;
Ransohoff and Engelhardt, 2012). A major unresolved issue is
whether microglia would have the capability of abandoning the
brain parenchyma and reach the lymph nodes. In fact, anti-
gen presentation in the CNS is thought to occur not in the
parenchyma, but in the meninges and choroid plexus, which con-
tain perivascular APCs, or by direct drainage of CNS antigens in
the cerebrospinal fluid from the subarachnoidal space to chan-
nels in the cribiform plate and ultimately into deep cervical lymph
nodes (Galea et al., 2007; Ransohoff and Engelhardt, 2012). Self-
antigens, including CNS antigens, do not produce a response
since self-reactive T cells are eliminated by clonal deletion in the
thymus. In the autoimmune disease MS, however, myelin-specific
T cells may escape from this tolerance mechanism and enter
the brain under some circumstances, leading to demyelination
(Goverman, 2011). Microglia seems to play a negative role in the
disease progression of EAE, the animal model of MS, as its deple-
tion reduces the severity of the disease (Heppner et al., 2005).
Whether this potentially detrimental role of microglia in EAE
is related to phagocytosis and/or antigen presentation remains
unknown (Ransohoff and Engelhardt, 2012).
RESPIRATORY BURST
During phagosomematuration the enzyme nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase is assembled in the
phagosome. NADPH oxidase catalyzes the reaction of NADPH
and oxygen to form NADP+, protons and the superoxide anion
(O2− ), in a process known as the respiratory burst (Minakami and
Sumimotoa, 2006). In the acidic pH of the phagosome, the super-
oxide anion is dismutated into hydrogen peroxide, H2O2, and
later transformed into other reactive oxygen species (ROS) which
contribute to killing of engulfed microorganisms and degrada-
tion of other cargo (Minakami and Sumimotoa, 2006). ROS
are extremely aggressive oxidants and can induce both apopto-
sis and necrosis (Pourova et al., 2010). Potentially toxic for the
phagocyte itself and the surrounding tissue, they are thought to
be released exclusively within the phagosome. In fact, NADPH
assembly is a tightly controlled process in phagocytes and includes
the recruitment to the phagosome of the catalytic core gp92phox
and p22phox, and the phosphorylation and membrane transloca-
tion of the regulatory subunit p47phox (Quinn and Gauss, 2004).
To ensure further regulation, the enzyme is rapidly deactivated,
resulting in transient activity (Decoursey and Ligeti, 2005). Most
of our understanding about the molecular mechanisms involved
in activation or the respiratory burst comes from studies per-
formed in neutrophils (Minakami and Sumimotoa, 2006), one
of the most important components of the immune system in the
defense against invading microorganisms. In microglia, the res-
piratory burst appears to be activated by phagocytosis through
similar mechanisms (Ueyama et al., 2004) after phagocytosis of
zymosan (a yeast cell wall preparation) (Newell et al., 2007) or
myelin (Williams et al., 1994), although it remains to be stud-
ied whether it is also activated after phagocytosis of other types
of cargo.
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Recently, it has been suggested that the NADPHoxidase can be
assembled in alternative locations, driving the respiratory burst in
the absence of phagocytosis (Bylund et al., 2010). Inmicroglia, the
respiratory burst is triggered by hypoxia/reoxygenation (Spranger
et al., 1998) and LPS (Qin et al., 2004) and results in the extracel-
lular release of ROS. In turn, inflammation-induced respiratory
burst leads to the release of glutamate by microglia, further con-
tributing to neuronal damage (Barger et al., 2007). Interestingly,
the microglial respiratory burst has been linked to induction of
neuronal apoptosis in the developing cerebellum in vitro (Marin-
Teva et al., 2004) and in the developing hippocampus in vivo
(Wakselman et al., 2008). In both studies, ROS-trapping by free
radical scavengers resulted in a significant rescue of neurons
from apoptosis. However, it remains unclear whether the acti-
vation of the respiratory burst was activated as a consequence
of phagocytosis or by independent mechanisms. While microglia
were clearly identified as the only source of ROS, the actual
intracellular location (i.e., in the phagolysosome or otherwise)
was not addressed (Marin-Teva et al., 2004; Wakselman et al.,
2008). The hippocampal study suggested indirectly that phago-
cytosis was indeed involved in the activation of the respiratory
burst, because mice lacking the complement receptor CR3 or
expressing mutant DAP12 showed reduced ROS production and
apoptosis (Wakselman et al., 2008). In spite of the pro-phagocytic
role of CR3 and DAP12, whether phagocytosis was disrupted in
these transgenic mice was not addressed. Two possible scenarios
remain open: in the first one, microglia would attack live (possi-
bly healthy) neurons, phagocytose them via CR3/DAP12, and kill
them intracellularly through the respiratory burst. In the second
scenario, an undetermined stimulus would activate microglia to
produce ROS via CR3/DAP12, which would be released extracel-
lularly and kill neurons, subsequently phagocytosed by microglia.
Clearly, more precise methods to quantify ROS (extracellular,
intracellular, phagolysosomal, etc.) (Bylund et al., 2010) and to
quantify phagocytosis and the nature of the cargo (Sierra et al.,
2010) are necessary to unravel the role of microglial phagocy-
tosis and respiratory burst in the developing hippocampus and
cerebellum.
MODULATION OF INFLAMMATORY RESPONSES
Historically, it was believed that phagocytosis of apoptotic cells
was a neutral immune event because it does not initiate an
inflammatory response [reviewed by Savill et al. (2002)]. Over
the past 20 years, it has been made clear that the phagocyto-
sis of apoptotic cells is largely anti-inflammatory (Stern et al.,
1996; Voll et al., 1997; Fadok et al., 1998). The inhibition of
pro-inflammatory cytokines synthesis requires tethering of the
phagocyte and the apoptotic cell, but not actual engulfment, fol-
lowed by paracrinal release of the anti-inflammatory cytokine
transforming growth factor beta (TGFβ), although the mech-
anism is not well-understood (Lucas et al., 2006). In addi-
tion, phagocytosis of other types of cargo such as myelin can
trigger an anti-inflammatory response (Liu et al., 2006). On
the contrary, phagocytosis of microbes associated with TLR
stimulation is pro-inflammatory (Erdman et al., 2009). The
anti-phlogistic response to phagocytosis of apoptotic cells also
occurs in microglia. Microglia phagocytosing apoptotic T cells
produce less tumor necrosis factor alpha (TNFα), a major pro-
inflammatory cytokine, than naïve microglia after LPS challenge
in vitro (Magnus et al., 2001). Similarly, phagocytosis of an apop-
totic neuronal line induces an increased production of TGFβ
and neural growth factor (NGF) in basal conditions; as well as
a decreased production of TNFα, nitrite, and prostaglandin E2
during LPS challenge in vitro (De Simone et al., 2003). These
anti-inflammatory effects are mediated by microglial PS receptor
(De Simone et al., 2002), as well as by TREM2 (Takahashi et al.,
2005). More recently it has been described that the immunosup-
pression induced by phagocytosis of apoptotic cells depends on
the presence of the complement protein C1q bound to apoptotic
cells, without which phagocytosis is pro-inflammatory (Fraser
et al., 2010). It is important to note that complement pro-
teins are present in the fetal bovine serum commonly used
in primary cultures. Nonetheless, it remains to be determined
whether the opsonin C1q is produced in the normal brain
and binds to apoptotic cells phagocytosed by microglia in vivo.
As a matter of fact, there is a big gap in our knowledge of
the type of inflammatory response resulting from phagocyto-
sis in vivo. The only in vivo data derives from a model of
prion disease, where phagocytic microglia have been qualita-
tively observed not to express the pro-inflammatory cytokine
interleukin 1beta (IL-1β) (Hughes et al., 2010). Because inflam-
mation has severe effects in the brain, including neurotoxicity
(Pickering et al., 2005) and epileptogenesis (Galic et al., 2012),
more research is necessary to conclusively determine whether
microglial phagocytosis of apoptotic cells is anti-inflammatory
in vivo.
MICROGLIAL PHAGOCYTOSIS IN PHYSIOLOGICAL
CONDITIONS
The widely accepted theory of linear activation of microglia
proposed by Gennadij Raivitch, William Streit, and collabora-
tors (Raivich et al., 1999; Streit et al., 1999) leads to the gen-
eralized assumption that microglia have to be preactivated or
primed by inflammatory challenge in order to become efficient
phagocytes (Kettenmann, 2007). More current are the terms M1
and M2 to describe a spectrum of states of microglial acti-
vation, similar to the polarization of macrophages responses
(Mantovani et al., 2002). The M1 phenotype or classic acti-
vation, is induced by PAMPs and pro-inflammatory cytokines,
and is characterized by high expression of TLRs, TNFα, co-
regulatory molecules for antigen presentation, and increased
release of ROS. On the contrary, the M2 phenotype, or alterna-
tive activation, is driven by stimuli such as interleukin 4 (IL-4)
or interleukin 13 (IL-13), and is characterized by the produc-
tion of anti-inflammatory interleukin 10 (IL-10) and TGFβ, and
higher expression of scavenger receptors. The M1 phenotype is
basically neurotoxic, while the M2 phenotype is more neuro-
protective (Durafourt et al., 2012). However it is not very clear
what is the relationship between the M1/M2 phenotypes and
phagocytosis. For instance, classic activation paradigms driving a
M1 phenotype lead to increased enhanced engulfment of apop-
totic cells in vitro (Chan et al., 2001; McArthur et al., 2010).
In addition, expression of phagocytic receptors is triggered by
many inflammatory and neurodegenerative paradigms in vivo
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assumedly inducing an M1 phenotype. On the other hand, a M2
phenotype driven by IL-4 and IL-13 increases the phagocyto-
sis of myelin (Durafourt et al., 2012), whereas a M2 phenotype
induced by glioma cancer stem cells reduces phagocytosis (Wu
et al., 2010). Regardless of the nomenclature used to describe
microglial phenotype after activation, the notion that microglia
require to be preactivated to phagocytose efficiently is challenged
by a number of recent papers showing that “resting” or “steady-
state” microglia are efficient phagocytes of spines and apoptotic
cells during physiological conditions in the adult and developing
brain (Dalmau et al., 2003; Sierra et al., 2010; Schafer et al., 2012)
(Figure 3).
MICROGLIAL PHAGOCYTOSIS OF SPINES
The capacity for microglia to phagocytose synapses has just
begun to be unraveled. In the juvenile visual cortex, most
microglia interact with synaptic elements (spines, axon termi-
nals, perisynaptic astrocytes, and synaptic clefts) (Tremblay et al.,
2010). Furthermore, live imaging indirectly supported a role for
microglia in pruning synapses, as spines contacted by microglia
where more frequently eliminated than non-contacted spines
(Tremblay et al., 2010). Qualitative examples of microglia con-
taining pre- and postsynaptic material labeled respectively with
SNAP25, a protein associated with presynaptic vesicles, and with
PSD95, a marker of the excitatory postsynaptic density, have
been shown in the developing postnatal hippocampus (Paolicelli
et al., 2011). Interestingly, a transient increase in dendritic spines
and immature synapses was observed in CX3CR1 knock-out
mice compared to wild-type mice, possibly due to a reduction
in microglial density (Paolicelli et al., 2011). Unfortunately, the
authors did not carry out a quantification of microglial phago-
cytosis of spines in CX3CR1-KO mice and thus the role of
the fractalkine receptor as an opsonin for microglial phagocy-
tosis of spines cannot be ruled out. Direct, quantified evidence
of microglia phagocytosing synapses (mostly, presynaptic ele-
ments) in the developing visual system has been recently provided
using confocal and electron microscopy (Schafer et al., 2012). In
the dorsal lateral geniculate nucleus (dLGN), active pruning of
synaptic inputs from the retinal ganglion cells (RGCs) produces
well-established ipsi- and contralateral innervations territories.
This pruning is at least partially mediated by complement-
mediated microglial phagocytosis, because mice deficient either
for the receptor CR3 or its ligand, C3, have decreased phagocy-
tosis of synaptic inputs, a sustained increase in synaptic density,
and deficits in segregation of the eye-specific territories com-
pared to wild-type mice (Schafer et al., 2012). Thus, unwanted
synapses seem to be tagged for removal by deposition of com-
plement proteins but—who is the decision maker? Do microglia
actively instruct which synapses must be removed? In vitro,
microglia produce several components of the complement cas-
cade, including C1q and C3, which are involved in the phago-
cytosis of neurites via CR3 (Linnartz et al., 2012). Interestingly,
removal of the monosaccharide sialic acid from the neural gly-
cocalyx is essential for C1q binding to neurites and subsequent
FIGURE 3 | Microglial phagocytosis in health. Motile, ramified,
unchallenged microglia phagocytose neurites (A, dendritic spines, axons)
and developmentally apoptotic neurons (B) in physiological conditions in
the adult and developing brain. (A) Surface-rendered CX3CR1+/EGFP
microglia (M; green) from the dorsolateral geniculate nucleus engulfing
ipsi- (blue, labeled with cholera-toxin (B) conjugated to Alexa 647) and
contralateral (red, labeled labeled with cholera-toxin (B) conjugated to
Alexa 594) inputs from retinal ganglion cells at postnatal day 5, when
robust pruning occurs. The insert is shown at higher magnification on the
right panel. (B) Iba-1 labeled microglia (M; cyan) branching a phagocytic
pouch which engulfs a newborn apoptotic/pycnotic cell (A; labeled with
the DNA dye DAPI, white), containing immunoreactivity for the
neuroblast marker polysialic acid neural cell adhesion molecule (red). The
cell is located in the subgranular zone of the hippocampus, where neural
stem cells (visualized in nestin-GFP mice) are located and proliferate
throughout adulthood. Images (A) and (B) are reprinted with permission
from Elsevier. (A) is reprinted from Schafer et al. (2012). (B) is reprinted
from Sierra et al. (2010).
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microglial phagocytosis in cultured neurons (Linnartz et al.,
2012). It seems plausible that synapse pruning is regulated by a
combination of mechanisms involving activity-dependent con-
trol of synaptic strength, alterations in the neuronal glycocalyx,
and tagging of altered synapses by microglial-release of com-
plement proteins, followed by removal of pre- and/or postsy-
naptic components by microglial phagocytosis. In contrast to
the more established mechanism of synaptic pruning by simple
retraction or degeneration of the input axon (Luo and O’Leary,
2005), microglia-dependent pruning is likely to requiremore time
and energy, while perhaps adding more levels of control to a
phenomenon which is essential to determine brain connectivity.
A possible similar combination of mechanisms has been observed
in the developmental pruning of dendrites in Drosophila neurons,
where branch retraction and local fragmentation of dendrites are
observed together with phagocytosis of caspase-labeled dendrites
by blood phagocytes (Williams and Truman, 2005;Williams et al.,
2006).
Overall, these data support a novel role for microglia in
monitoring synapses in the healthy developing brain, with poten-
tially profound consequences for diseases in which neural con-
nectivity and microglial activation concur. One such disease is
transient ischemia, in which the turnover of synapses (Zhang
et al., 2005) as well as microglial activation and inflammation
increase (Lambertsen et al., 2012). In the ischemic cerebral cor-
tex microglial contacts with synaptic boutons last-longer (1 h)
than in the control cortex (5min) (Wake et al., 2009). While
it is tempting to speculate that extended contacts are related
to synapse pruning, only a minority of boutons disappeared
after being contacted by microglia and phagocytosis was not
observed (Wake et al., 2009). In autism spectrum disorders
(ASD), a complex set of diseases with unknown pathophysi-
ology, both neural hyperconnectivity (Testa-Silva et al., 2012)
and inflammation (Vargas et al., 2005) develop. In MECP2-
deficient mice, a model of Rett syndrome, microglia has defec-
tive phagocytosis in vitro, and preventing phagocytosis in the
mice exacerbates the symptoms (Derecki et al., 2012). The
potential defects in spine and/or apoptotic cell phagocytosis
by microglia in Rett syndrome and other ASDs remain to be
elucidated.
MICROGLIAL PHAGOCYTOSIS OF APOPTOTIC CELLS DURING BRAIN
DEVELOPMENT AND IN NEUROGENIC NICHES
A detailed map estimating microglial phagocytosis during devel-
opment showed an overall high efficiency of microglia-removing
apoptotic cells (Dalmau et al., 2003). At time points where apop-
tosis is maximal, microglia phagocytose 97% of apoptotic cells in
the fimbria (embryonic day E18), 88 and 100% in the CA region
of the hippocampus (E16 and postnatal day 0, respectively),
18 and 86% in the cerebral cortex (E16 and P0, respectively),
and 93% in the dentate gyrus (P0). These estimates match well
with the phagocytic efficiency of microglia in the dentate gyrus
throughout adulthood, where new neurons are continuously pro-
duced. From 1 to 12 months of age in mice, microglia phago-
cytose over 90% of the cells undergoing apoptosis (Sierra et al.,
2010). Nonetheless, the phagocytic capacity is region-specific,
as microglia only phagocytose 50% of the apoptotic cells at the
maximum period of cell death (P3) in the developing cerebel-
lum (Ashwell, 1990; Marin-Teva et al., 2004; Wakselman et al.,
2008).
But, what happens to the remaining apoptotic cells? A pos-
sible interpretation is that they will be engulfed by microglia at
a later time point, so that the percentage of non-phagocytosed
apoptotic cells is an indirect representation of the “find-me” time.
Alternatively, these cells may be disposed of through other mech-
anisms, such as phagocytosis by other cell types. Microglia are
considered the professional brain phagocytes. Non-professional
phagocytes such as astrocytes delay phagocytosis for several hours
(Parnaik et al., 2000) and engulf with much lower capacity
(Magnus et al., 2002), at least in vitro. Nonetheless, other cell
types mediate phagocytosis of apoptotic cells in vivo during devel-
opment. For instance, in the developing cerebellum (P7) phago-
cytosis of apoptotic oligodendrocytes is carried out by specialized
astrocytes, the Bergmann glia, albeit at a relative low efficiency
(55% of apoptotic cells engulfed) (Parnaik et al., 2000). In the
developing retina, phagocytosis is executed by microglia and
Müller cells (Egensperger et al., 1996), and throughout lifetime
the excess of photoreceptors membrane shredded is phagocy-
tosed by retinal pigment epithelium (RPE) cells (Kevany and
Palczewski, 2010). While considered non-professional phago-
cytes, RPE cells have an enormous phagocytic capacity, as they
engulf up to 10% of the photoreceptors volume on a daily
basis (Kevany and Palczewski, 2010). In the adult hippocampal
neurogenic cascade, only microglia have been observed to phago-
cytose apoptotic newborn cells (Sierra et al., 2010). Nonetheless,
neural-committed neuroprogenitors (neuroblasts, labeled with
doublecortin) have some phagocytosing capabilities which con-
tribute to the maintenance of the neurogenic cascade, although
what they actually take in remains to be determined (Lu et al.,
2011). In peripheral ganglia, the apoptotic neurons are phago-
cytosed by satellite glial cell precursors (Wu et al., 2009). It
has been speculated that low microglial density in some regions
may be related to the recruitment of non-professional phago-
cytes (Parnaik et al., 2000) but the reasons behind this promis-
cuous phagocytosis during brain development are not known.
Assumedly, microglial phagocytosis contributes to the mainte-
nance of tissue homeostasis during development and in adult
neurogenic niches by rapidly removing cellular debris. It can also
be speculated that microglial phagocytosis takes a more active
role in regulating neurogenesis. For instance, after phagocyto-
sis, cultured microglia produce higher levels of TGFβ and NGF
(De Simone et al., 2003), which are negative and positive regula-
tors of hippocampal neurogenesis, respectively (Buckwalter et al.,
2006; Frielingsdorf et al., 2007). After stroke, microglia in the sub-
ventricular zone (SVZ) show a pro-neurogenic phenotype which
includes the expression of insulin-like growth factor 1 (IGF-1)
(Thored et al., 2009), another well-known inducer of neuroge-
nesis (O’Kusky et al., 2000). Stroke-responding microglia were
labeled with ED1 but unfortunately phagocytosis was not quanti-
fied. Future research will delineate the contribution of microglia
to neurogenesis.
The high efficiency of phagocytosis, that is, the high cou-
pling between apoptosis and phagocytosis, has also suggested the
idea that phagocytosis executes the final stages of apoptotic cell
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death. Apoptosis can be initiated by two major pathways: the
extrinsic pathway, driven by activation of membrane receptors
such as CD95, or the TNFα receptor; and the intrinsic path-
way, initiated by cellular stress (DNA mutations, deprivation of
survival factors, Ca2+ overload, etc.) (Reubold and Eschenburg,
2012). While the signaling cascades are complex and varied, a
common mechanism of execution of most forms of apoptosis
is the formation of the apoptosome, a macromolecular complex
which activates the effector caspase 3, a cystein protease respon-
sible for DNA fragmentation, membrane blebbing, cytoskeleton
degradation, and the other major hallmarks of apoptosis (Blank
and Shiloh, 2007). In addition to the cell-autonomous degra-
dation mediated by caspases, phagocytes may also contribute to
carry out death. For instance, mutations in C. elegans engulf-
ment genes, such as ced-1, permit the survival of cells that would
normally die (Reddien et al., 2001). In addition, DNA fragmen-
tation is not only mediated by cell-autonomous caspase-activated
DNase (CAD) but can also be partly attributed to postengulfment
degradation by lysosomal enzymes (McIlroy et al., 2000). The
lysosomal DNase II of macrophages contributes to thymocyte
DNA degradation during thymus development (Kawane et al.,
2003). Whether this mechanism is universal to macrophages and
microglia is unknown, because DNase II deficient mice embryos
show severe defects in the thymus and kidney, but not in the
brain (Kawane et al., 2003). Nevertheless, these evidences sug-
gest that, since there are no stop points in apoptosis analog
to the check points found in mitosis, phagocytosis is the de
facto mechanism to discriminate between moribund and dead
cells.
In some circumstances this effective coupling may have detri-
mental consequences. It has been suggested that if phagocytosis
is too effective, it may lead to the removal of cells which will
otherwise have time to repair themselves (Kao et al., 2011).
For example, the macrophages of mice and worms deficient in
the secreted glycoprotein progranulin have an enhanced phago-
cytic efficiency, which is perhaps related to the neurodegen-
eration found in human patients of familial frontotemporal
lobar degeneration, mostly caused by mutations in progranulin
(Kao et al., 2011). Going further, microglial phagocytosis may
be the primary cause of cell death under some circumstances.
Macrophages are known to interact with live cells but disen-
gage quickly because of the “don’t eat-me” signals (Ravichandran,
2010). Under some circumstances, however, phagocytes kill live
cells. For instance, macrophages induce apoptosis of normal vas-
cular endothelial cells of the hyaloid vascular system as well as
papillary cells in the developing mouse eye (Lang and Bishop,
1993; Diez-Roux and Lang, 1997). Similarly, microglial phago-
cytosis has been reported to induce the death of viable, motile
non-apoptotic polymorphonuclear neutrophils in organotypic
hippocampal cultures in which ischemia was induced by oxy-
gen and glucose deprivation (Neumann et al., 2008). Further,
in inflammatory conditions driven by activation of TLR2 or
TLR4, microglial phagocytosis induces cerebellar granule cell
death by a complex mechanism involving the microglial release
of peroxynitrite which leads to a transient exposure of PS in
the neurons and opsonization with MFG-E8, followed by recog-
nition through the vitronectin receptor and phagocytosis by
microglia in vitro (Neher et al., 2011) and in the striatum in vivo
(Fricker et al., 2012). However, high concentrations of perox-
ynitrite lead to increased intracellular calcium, exposure of PS,
activation of caspases and, ultimately, apoptotic cell death (Leist
et al., 1997). Neurons dying from primary phagocytosis do not
express features of apoptosis or necrosis, and the actual mech-
anism executing death is an open area of research (Brown and
Neher, 2012). Thus, phagocytosis represents a wide range of
responses, from the mere passive clearing of apoptotic cells and
the active execution of final stages of apoptosis during devel-
opment to the aberrant killing of live, healthy neurons during
inflammation.
MICROGLIAL PHAGOCYTOSIS IN PATHOLOGICAL
CONDITIONS
Overall, phagocytosis is considered a beneficial phenomenon and
its alteration has been linked to autoimmune diseases (Nagata
et al., 2010). In addition, the best-known case of a phagocytic sys-
tem disease is the relatively rare but lethal Nasu–Hakola disease
or polycystic lipomembranous osteodysplasia with sclerosing
leukoencephalopathy (PLOSL), due to loss-off-function muta-
tions of TREM2 and/or DAP12 (Paloneva et al., 2002). PLOSL is
characterized by defects in bone resorption by osteoclasts lead-
ing to the formation of cysts, as well as dementia (Bianchin
et al., 2004). The contribution of microglia to the pathology of
PLOSL remains obscure because DAP12-deficient mice do not
reflect the human neurodegenerative pathology. Initial reports
showed altered synaptogenesis and hypomyelination as well as
behavioral impairments in mice deficient or expressing loss-off-
function mutations of DAP12 (Kaifu et al., 2003; Roumier et al.,
2004). In the mouse brain, DAP12 is exclusively expressed in
microglia, suggesting an interesting link between microglia and
synaptic plasticity through a yet unknown mechanism (Roumier
et al., 2004). More recent studies have shown a strong demyeli-
nation in the brain of DAP12-deficient human patients; however
this demyelination did not seem to correlate with changes in
microglial density or activation (Satoh et al., 2011). Therefore,
the exact pathophysiology ofmicroglia in PLOSL patients remains
unclear. Nonetheless, there are many other pathological condi-
tions related to the microglial phagocytosis of apoptotic cells,
viral and bacterial pathogens, tumor cells, Aβ, myelin, and axonal
debris (Figure 4).
MICROGLIAL PHAGOCYTOSIS OF DEAD CELLS IN PATHOLOGICAL
CONDITIONS
Neurodegeneration by apoptosis is a major part of several brain
diseases such as stroke, epilepsy, prion disease, Alzheimer’s dis-
ease (AD), and Parkinson’s disease (PD). Microglial phagocytosis
of apoptotic cells in pathological conditions is assumed to be
highly efficient, possibly because of an extrapolation of the phys-
iological phagocytosis during brain development, however this
may not be always the case. For instance, there is qualitative
evidence that apoptotic neurons in a mouse model of neonatal
stroke by medial cerebral artery occlusion (MCAO) are poorly
phagocytosed by activated microglia compared to the contralat-
eral healthy hemisphere, where less apoptosis occurs (Faustino
et al., 2011). The reasons behind this low phagocytosis in stroke
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FIGURE 4 | Microglial phagocytosis in disease. In pathological conditions
microglia is challenged and usually assumes a hypertrophic morphology.
Challenged microglia phagocytose apoptotic and necrotic cells (A,B). In some
inflammatory conditions, microglial phagocytosis can kill healthy neurons (C).
Microglia also phagocytose axonal and myelin debris resulting from Wallerian
degeneration of severed axons (D). (A) Surface-rendered fms-EGFP
microglia (M; cyan) from the adult hippocampus phagocytosing three
apoptotic/pycnotic cells (labeled with DAPI, white), in a mouse systemically
challenged with bacterial lipopolysaccharides (5mg/kg). (B) Electron
microscopy microphotograph of embryonic (E20) microglia (N, microglial
nucleus) from the rat cingulate cortex following maternal hypoxia (1 day)
containing four engulfed dead cells. In the developing brain, hypoxia induces
a whole range of death mechanisms, including apoptosis, pathological
apoptosis, and necrosis (Blomgren et al., 2007). (C) Time-lapse imaging of
microglia (red arrow) engulfing a live neuron (yellow arrow) in a co-culture
challenged with the TLR2 agonist lipoteichoich acid (50μg/ml).
(D) Orthogonal projection of a confocal z-stack showing the engulfment of
degenerated axons (labeled with tdTomato, red) by microglia (labeled with
Iba1, green; nucleus labeled with DAPI, blue) in a co-culture model. Scale
bars, 5μm. Image (A) is reprinted with permission from Elsevier from Sierra
et al. (2010). Image (B) is reprinted with permission from Elsevier from Li
et al. (1998). Image (C) is reprinted with permission from Neher et al. (2011),
Copyright 2011. The American Association of Immunologists., Inc. Image
(D) is reprinted with permission from Hosmane et al. (2012).
are unknown, but it has been speculated that high levels of
pro-inflammatory cytokines produced by astrocytes and vessels
may be the culprit (Faustino et al., 2011). However, microglial
phagocytosis of apoptotic cells in vitro is increased by the pro-
inflammatory interferon gamma (IFNγ), but it remains unaltered
by TNFβ or TGFβ (Chan et al., 2001). Prion disease is another
condition where microglial phagocytosis is impaired. In vitro, the
pathogenic form of prion protein (PrPSc), reduces the phago-
cytosis of latex beads (Ciesielski-Treska et al., 2004); however
in vivo (ME7 model of prion disease) microglia show increased
phagocytosis of beads, and enhanced expression of the phagocytic
machinery genes, including scavenger receptors, cathepsins, and
proteins of the respiratory burst. In addition, qualitative phagocy-
tosis of neuronal debris by microglia suggests that the microglial
phagocytic machinery in prion disease is not disrupted (Hughes
et al., 2010), but microglia do fail to phagocytose prion protein
(PrPSc), which accumulates in the brain and leads to neurode-
generation (Hughes et al., 2010). PD is one more example in
which the phagocytosis behavior of microglia is altered. Here
the phagocytosis of latex beads is prevented by the aggregated
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form, and enhanced by the monomeric form of alpha synuclein,
which are found in the parenchyma and the CSF of parkinsonian
patients, respectively (Park et al., 2008). Moreover, peripheral
blood monocytes from PD patients, compared to age-matched
controls, exhibit decreased phagocytosis of latex beads ex vivo
(Salman et al., 1999), however defects in microglial phagocy-
tosis have not been reported in vivo so far. Again, the lack
of a standardized approach to quantify microglial phagocyto-
sis hampers our understanding of its role in brain disorders
where it is expected to play a significant role in removing cellular
debris.
Death by necrosis is also an important component of many
brain diseases. Contrary to apoptosis, necrosis is characterized
by bursting of the cell membrane and spillover of cellular con-
tents (Savill et al., 2002). Necrosis remains an obscure pro-
cess, and molecular details of its execution are not well-known.
Two main forms have been recognized: accidental necrosis, or
cell lysis, by exposure of toxins, physical damage, freezing, etc.;
and necrosis-like programmed cell death (PCD), which involves
specialized caspase-independent signaling pathways such as the
apoptosis-inducing factor (AIF) or cathepsins, and evolves with-
out chromatin condensation (Leist and Jaattela, 2001). While
accidental necrosis is unavoidable unless the stimulus is removed,
cells can be rescued from necrotic PCD. The mechanisms of
necrotic cells recognition by macrophages and microglia are not
fully understood but may involve similar signaling pathways to
the recognition of apoptotic cells. For instance, in some forms
of necrotic PCD, exposure of PS by calcium-independent sig-
nals triggers recognition of necrotic cells by macrophages and
microglia (Hirt et al., 2000; Hirt and Leist, 2003). One alternative
mechanism could be the passive release of high mobility group
1 protein (HMGB1) by necrotic cells, which binds to the recep-
tor for advanced glycation end products (RAGE) in phagocytes
and triggers inflammation (Scaffidi et al., 2002). It is worth noting
that HMGB1 is not released by apoptotic cells even when they fail
to be phagocytosed and transform into secondary necrotic cells
(Scaffidi et al., 2002). HMGB1 is also released during ischemia
(assumedly, from the necrotic core) in stroke patients and in mice
subjected to MCAO, launched an inflammatory response, which
is detrimental for neuronal survival (Kim et al., 2006;Muhammad
et al., 2008). Initial reports suggested that microglia does not
mount an inflammatory response when co-cultured with necrotic
PC12 neurons (De Simone et al., 2003). Others have shown that
the phagocytosis of necrotic PCD Jurkat cells reduces the release
of TNFα by microglia (Hirt and Leist, 2003). More recently, it has
been shown that when co-cultured with necrotic HT22 neurons
microglia do indeed express higher levels of pro-inflammatory
cytokines (TNFα, IL-6), pro-inflammatory enzymes (nitric oxide
synthase, 2-cyclooxygenase), MHC-II, and the integrin CD11b
through a mechanism involving MYD88, a TLR adapter protein
(Pais et al., 2008). In summary, very little is known about the effi-
ciency and consequences of microglial phagocytosis of necrotic
cells.
Death of living cells by phagocytosis, recently termed “phagop-
tosis,” might contribute to the pathophysiology of some diseases
where inflammation, the main trigger for phagoptosis, occurs.
For instance AD, which characterized at the histological level
by plaques of Aβ as well as neurofibrillary tangles, has a strong
inflammatory component (Johnston et al., 2011). In vitro, low
concentrations of Aβ (1–42) (nanomolar range) lead to activation
of microglia and an inflammatory response, which is partly
responsible for neuronal damage (Maezawa et al., 2011). In
this situation, either depleting microglia, blocking vitronectin
receptors, inhibiting cytoskeleton polymerization, or preventing
recognition of PS with annexin V, all prevent neuronal death
induced by nanomolar Aβ (Neniskyte et al., 2011). These data
suggest that phagoptosis might be partly responsible for neu-
ronal death induced by Aβ, perhaps providing an explanation
for the low numbers of dead neurons found in AD (Neniskyte
et al., 2011). Nonetheless, death by apoptosis has been docu-
mented in AD patients and in animal models of AD, although
it is assumed to occur at low levels over a long period of time
(Shimohama, 2000).We argue that the clearance time for phagop-
totic neurons is likely to be longer than for phagocytosed apop-
totic neurons, because phagoptotic cells fail to activate caspases
and other mechanisms of self-destruction and rely exclusively on
microglia for degradation (Brown and Neher, 2012). Time-lapse
imaging experiments suggest that engulfing a live neuron may
take microglia under 2 h (Neher et al., 2011) (Figure 4), how-
ever the time to fully degrade it has not been estimated. As a
longer clearance time implies a higher probability of phagocyto-
sis detection, it should then be possible to visualize and quantify
microglial engulfment of live cells in AD or in other inflammatory
diseases to ultimately determine the contribution of phagoptosis
to brain pathologies in vivo.
MICROGLIAL PHAGOCYTOSIS OF INVADING MICROORGANISMS
In the adult and developing brain, microglia are capable of
phagocytosing many pathogens, including bacteria (Escherichia
coli, Streptococcus pneumonia, Staphylococcus aureus, Enterococcus
faecalis), yeast (Saccharomyces cerevisiae), and fungus (Candida
albicans) (Kaur et al., 2004; Falsig et al., 2008; Shah et al., 2008;
Hadas et al., 2010; Ribes et al., 2010; Peppoloni et al., 2011;
Kochan et al., 2012). Different PAMPs are recognized by differ-
ent receptors: for instance, recognition of S. aureus peptidoglycan
is mediated by TLR2 (Kielian et al., 2005); recognition of E. coli
LPS is mediated by TLR4 (Sivagnanam et al., 2010); and recogni-
tion of S. cerevisiae β-glucans (such as zymosan) is mediated by
Dectin1, CR3, and the mannose receptor (MR, CD206) (Hadas
et al., 2010). TLR2 and 4 are constitutively expressed by microglia
(Bsibsi et al., 2002) and recognition of their ligands enhances
phagocytosis (Ribes et al., 2010; Kochan et al., 2012), support-
ing the capacity of microglia to efficiently engulf and degrade
infecting microorganisms. For instance, E. coli bacteria injected
into the corpus callosum of early postnatal rats are engulfed in
large numbers 1–3 h after injection, and are completely elimi-
nated in 24 h (Kaur et al., 2004). In contrast, phagosomes were
found within microglial cells up to 7 days after (Kaur et al.,
2004), suggesting that degradation and killing of living microor-
ganisms is a time-consuming process. Phagocytosis of bacteria
activates the inflammatory cascade in microglia, inducing the
expression of pro-inflammatory cytokines (TNFα), TLRs (TLR4,
TLR9), complement receptors (CR3), scavenger receptors (SRA),
and MHC-II (Sivagnanam et al., 2010). Although the data on
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microglial phagocytosis of microorganisms is not abundant, it
seems to suggest a high capacity to fight against brain infections
such as meningitis.
MICROGLIAL PHAGOCYTOSIS OF TUMOR CELLS
Brain tumors are very aggressive and have extremely poor prog-
nosis possibly due to a failure of the innate and adaptive
immune response to efficiently eliminate them. Tumor-associated
microglia and macrophages (TAMs) are found in large num-
bers in human glioblastoma and have a complex and bidirec-
tional relationship with glioma cells which has been reviewed
in detail elsewhere (Watters et al., 2005). On one hand, glioma-
initiating cells contribute to the recruitment of TAMs into the
tumor mass (Yi et al., 2011) and polarize them toward a M2
phenotype (Wu et al., 2010). On the other hand, TAMs con-
tribute to glioma progression by enhancing tumor migration and
proliferation through growth factors, angiogenic molecules, and
enzymes degrading the extracellular matrix (Watters et al., 2005).
Unfortunately, glioma cells are rarely phagocytosed by TAMs in
mouse models of glioma (Galarneau et al., 2007). Microglia from
human glioblastoma patients do have the capability of phagocy-
tosing latex microbeads ex vivo (Hussain et al., 2006), however
in vitro studies have shown that co-culture with tumor cells
decreases bead phagocytosis after a transient increase (Voisin
et al., 2010). Further, it seems that tumor cells evade phago-
cytosis by lacking in their membrane the appropriate “eat-me”
signals. In fact, microglia do phagocytose tumor cells which
have been previously induced apoptosis with the cytotoxic agent
etoposide (Chang et al., 2000) or UV light (Kulprathipanja
and Kruse, 2004), although many tumor cells decrease their
sensitivity to apoptosis inducers during oncogenic transforma-
tion (Maher et al., 2001). This data has suggested the use of
alternative therapies to promote tumor cell apoptosis, such as
oncolytic viruses, which selectively replicate in tumor cells, lead-
ing to their destruction (Zeyaullah et al., 2012). This therapy,
while safe, has been proven ineffectual because TAMs clear
the viruses away from the tumor (Fulci et al., 2007). While
the literature confirms that TAM phagocytosis of tumor cells
is not very effective, others have suggested that some tumor
cells, particularly in highly invasive tumors such as glioblas-
toma, phagocytose neighboring cells perhaps as a way to fuel
their constant growing [reviewed by Huysentruyt and Seyfried
(2010)].
MICROGLIAL PHAGOCYTOSIS OF Aβ DEPOSITS
Aβ is a small peptide produced by proteolytic cleavage from amy-
loid precursor protein (APP) by β- and γ-secretases. The most
pathogenic form is Aβ (1–42), which forms fibrils, insoluble
aggregates found in amyloid plaques in the brains of AD patients,
as well as human immunodeficiency virus (HIV)-associated neu-
rocognitive disorders (Xu and Ikezu, 2009). A major effort has
been put into developing therapies to lower the amyloid bur-
den. Aβ reduction can occur either by decreasing its synthesis
rate (e.g., with secretase inhibitors); or by increasing its elim-
ination rate. The particular location of microglia surrounding
plaques in human patients and mouse models of AD lead to
the early suggestion that they could be responsible for releasing
Aβ and forming the plaques (Lai and McLaurin, 2012). While
microglia can synthesize Aβ in vitro (Banati et al., 1993), APP
mRNA is not found in microglia of human AD brains (Scott
et al., 1993). It was alternatively proposed that microglia could
be responsible for phagocytosing Aβ and contribute to its clear-
ance (Paresce et al., 1996). In vitro, microglia recognizes and
engulfs fluorescently labeled fibrillary Aβ through a variety of
receptors, including scavenger receptors (Paresce et al., 1996),
TLR2 (Liu et al., 2012), and the TLR4-interacting molecule, CD14
(Liu et al., 2005). Further, Aβ induces a positive chemotaxis
of microglia via TGFβ (Huang et al., 2010), possibly explain-
ing their location around plaques. Recent live imaging experi-
ments have shown that microglia is rapidly attracted to already
formed plaques in a mouse model of AD with mutated APP
and presenilin 1 (a protein of the γ-secretase complex) (Meyer-
Luehmann et al., 2008), strongly suggesting that microglia does
not participate in the initial stages of plaque formation and con-
firming the chemotactic nature of Aβ. Importantly, the size of
the plaques remained constant and no evidence of phagocyto-
sis or plaque clearance was obtained (Meyer-Luehmann et al.,
2008). In agreement, a detailed 3D reconstruction of microglia
and amyloid fibrils in APP mutated mice showed that microglial
processes and amyloid fibrils were interlaced forming a network,
but Aβ was not found within microglia, further suggesting that
microglia does not phagocytose Aβ in vivo (Stalder et al., 2001).
The failure of microglia to clear Aβ plaques of AD patients
is unclear. Cultured microglia engulf and partially degrade Aβ
in vitro over the first 3 days, but no additional degradation and
a slow release of intact Aβ is found afterwards (Chung et al.,
1999). Furthermore, microglia from old mutant APP/presenilin
1 mice have a decreased expression of phagocytic genes (SRA,
CD36, RAGE, etc.) and increased expression of pro-inflammatory
cytokines (TNFα, IL-1β), compared with age-matched wild type
mice (Hickman et al., 2008), but both findings cannot explain
the failure of microglia to sufficiently clear Aβ plaque in vivo.
The role of inflammation in Aβ clearance is also not resolved.
In vitro, inflammatory challenge by LPS, TNFα, IL-1β, or IFNγ
inhibits fibrillary Aβ phagocytosis, whereas anti-inflammatory
cytokines had no effect (Koenigsknecht-Talboo and Landreth,
2005). Aβ phagocytosis is blocked by the anti-inflammatory
celecoxib (Persaud-Sawin et al., 2009), but not by minocyline
(Familian et al., 2007). In vivo, LPS administered locally either
transiently reduced (Herber et al., 2004), or enhanced (Qiao
et al., 2001) Aβ load in mouse models of AD. The fractalkine
receptor, a regulator of phagocytosis, has been found to con-
tribute to the Aβ burden by some (Lee et al., 2010; Liu et al.,
2010) but not others (Fuhrmann et al., 2010). Importantly, com-
mon treatments for HIV and AD may be detrimental for Aβ
clearance, at least in vitro. HIV protease inhibitors either block
Aβ degradation or enhance secretion of non-degraded Aβ by
macrophages (Lan et al., 2012). Similarly, γ-secretase inhibitors
prevent microglial Aβ engulfment (Farfara et al., 2011). Another
point of controversy is the participation of invadingmacrophages.
The blood-brain barrier (BBB) is partially disturbed in AD
patients, facilitating the extravasation of circulating monocytes
(Lai and McLaurin, 2012). Macrophages have higher Aβ capacity
intake than microglia in vitro (Lai and McLaurin, 2012), and
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ablation experiments have suggested that the Aβ burden is cleared
by blood-bornemacrophages, but not resident microglia (Simard
et al., 2006). The issue is further complicated by the fact that
experimental interventions such as irradiation of mice lead to
invasion of blood-monocytes into the brain parenchyma and that
macrophages and microglia are phenotypically indistinguishable
by surface markers.
MICROGLIAL PHAGOCYTOSIS OF MYELIN AND AXONAL DEBRIS
The only available data on microglial phagocytosis of axonal
debris comes from in vitro models. In cortical explants where
growing neurites were sectioned, the debris was cleared by added
microglia (Tanaka et al., 2009). In a compartmentalized co-
culture model where neurons were grown in a chamber and
their axons extended in bundles through microchannels, axo-
tomy, or nitric oxide treatment-induced axonal degeneration and
microglia rapidly cleared the axonal debris (Hosmane et al.,
2012). Interestingly, the mechanisms of recognition of axonal
debris seem to be different from those of apoptotic cells (Tanaka
et al., 2009). A candidate receptor is TIR domain-containing
adapter inducing interferon beta (TRIF). The clearance of axonal
debris is prevented by blocking TRIF signaling in vitro, and TRIF-
deficient mice have a smaller percentage of microglia containing
neurofilament-positive axonal material after dorsal root axotomy
(Hosmane et al., 2012). In both set ups, axonal debris (lack-
ing myelin) had a detrimental effect on axon regrown, which
was prevented by microglial phagocytosis (Tanaka et al., 2009;
Hosmane et al., 2012), suggesting that enhancing microglial
phagocytosis is a novel therapeutical tool in traumatic brain
injuries.
More attention has been put into the mechanisms of myelin
debris clearance, particularly during MS and in spinal cord and
nerve injuries. In spinal cord injury, the degeneration of the
severed axons through anterograde or Wallerian degeneration
(WD) is followed by degradation of myelin and apoptosis of
myelinating cells, oligodendrocytes (Crowe et al., 1997). The
etiology ofMS remains to be fully elucidated and several hypothe-
ses have been proposed to explain the demyelination found in
patients, from an autoimmune attack to myelin followed by
axonal degeneration, to the developmental, environmental, or
virus-induced degeneration of axons by WD followed by myelin
degradation; in both cases, myelin debris accumulates (Stys et al.,
2012). Myelin proteins such as Nogo are well-known to inter-
fere with axonal regeneration and repair, therefore an efficient
myelin clearance is an absolute requirement for recovery (Wang
et al., 2002). Furthermore, myelin inhibits its own phagocytosis
through myelin CD47 binding to microglia and macrophages sig-
nal regulatory protein α (SIRPα) (Gitik et al., 2011). Contrary to
the peripheral nervous system (PNS), myelin clearance after WD
is very inefficient in the CNS [reviewed in Gaudet et al. (2011)].
In PNS lesions, the myelinating Schwann cells are the major
phagocytic population in the first few days, followed by invad-
ing macrophages (Hirata and Kawabuchi, 2002). Importantly,
macrophages express Nogo receptors NgR1 and NgR2, which
facilitate their migration out of the healing nerve, thus resulting
in the resolution of the inflammatory response (Fry et al., 2007).
In culture, myelin-phagocytosing macrophages inhibit T cell pro-
liferation, further containing the immune response (Bogie et al.,
2011). The rapid clearance of myelin and resolution of the
immune response is greatly responsible for regeneration after
nerve injury.
In contrast, CNS regeneration after trauma does not occur,
and microglial poor phagocytosing capabilities together with
poor or slow recruitment of macrophages are partly to blame
(Gaudet et al., 2011). In vitro, microglia recognize and phagocy-
tose myelin through CR3, SRA, and FcRs among other receptors
(Smith, 2001). Microglia do phagocytosemyelin to some extent in
mouse models of MS, a phenomenon which is stimulated by the
presence of MBP-reactive T cells (Nielsen et al., 2009). However,
myelin debris is still observed in the human spinal cord years
after the injury (Buss et al., 2004). Together with insufficient
activation of microglia, the absence of autoreactive antibodies,
and the subsequent lack of activation of FcRs in traumatic brain
injury have been suggested to explain why microglia phagocy-
tose myelin in MS but not in spinal cord injury (Rotshenker,
2003). Microglial phagocytosis of myelin after hemisection of
the ascending sensory tract is increased after treating the mice
with LPS, resulting in decreased myelin debris, but, unfortu-
nately, no axonal regeneration (Vallieres et al., 2006), possibly
because of the pro-inflammatory phenotype induced by LPS.
More recently, a microglial phenotype supportive of remyelina-
tion has been described (Olah et al., 2012). During the remyelina-
tion phase after cuprizone-induced demyelination in the corpus
callosum, a mouse model of MS, myelin-phagocytosing microglia
express genes involved not only in phagocytosis but also in
the activation, migration, proliferation, and differentiation of
oligodendrocytes precursor cells (Olah et al., 2012). While it
remains to be directly assessed whether myelin phagocytosis trig-
gers this remyelination-supportive phenotype, this data suggests
that the beneficial consequences of enhancing microglial phago-
cytosis of myelin may be two-fold: clearingmyelin and facilitating
remyelination.
CONCLUSION
In conclusion, microglial phagocytosis is a pivotal mechanism of
clearance of cellular debris in health and disease. Like Janus, the
roman god of war and peace, microglial phagocytosis has bene-
ficial (e.g., anti-inflammatory) and detrimental (e.g., respiratory
burst) consequences for tissue homeostasis which remain largely
unexplored in vivo. In particular, the establishment of standard-
ized methods to quantify microglial phagocytosis of different
types of cargo, as well as the development of novel tools to specif-
ically block recognition, engulfment, and degradation of cargo,
will undoubtedly delineate the ultimate impact of microglial
phagocytosis in vivo.
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